Cantabio Pharmaceuticals Inc. | WebDisclosure

Basculer en Français

11221	Companies
248845	Keywords
176654	Articles
134674	Press releases

Headlines Articles Press releases Cantabio Pharmaceuticals Inc.

Home
Companies
Cantabio Pharmaceuticals Inc.

PRESS RELEASE

published on 02/06/2024 at 16:00, 2 years 8 months ago

Cantabio Pharmaceuticals Awarded Major Grant from The Michael J. Fox Foundation for the Development of a novel DJ-1 Protein Replacement Therapy for the Treatment of Parkinson’s Disease
Cantabio Pharmaceuticals, Inc. receives major grant from MJFF for the development of DJ-1 replacement therapy aimed at treating Parkinson's disease by increasing DJ-1 levels in patients and preventing disease progression

Precision Medicine Cantabio Pharmaceuticals MJFF Grant DJ-1 Replacement Therapy Parkinson's Disease

Accesswire

Published on 10/23/2026 at 16:00, 2 minutes ago

Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/23/2026 at 13:23, 2 hours 39 minutes ago

Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 3 hours 2 minutes ago

First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 13:00, 3 hours 2 minutes ago

First Canadian Graphite Inc. annonce un financement accréditif
Published on 10/23/2026 at 02:20, 13 hours 42 minutes ago

Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering

View all ACCESSWIRE

EQS Group

Published on 10/23/2026 at 15:48, 13 minutes ago

EU RIS CSDS Individual - Appointment of Custodian
Published on 10/23/2026 at 15:47, 15 minutes ago

EU RIS CSDS Index - Appointment of Custodian
Published on 10/23/2026 at 15:40, 22 minutes ago

Shanghai, Hamburg seek closer ties as friendship turns 40
Published on 10/23/2026 at 15:25, 36 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/23/2026 at 15:24, 37 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

Les Echos

Published on 10/23/2026 at 07:00, 9 hours 2 minutes ago

Safran reports third quarter 2026 revenue
Published on 10/23/2026 at 07:00, 9 hours 2 minutes ago

Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 22 hours 2 minutes ago

THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 22 hours 2 minutes ago

THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 22 hours 2 minutes ago

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

View all LES ECHOS COMFI WIRE